Study: Skull skin may shunt current during brain stimulation | Animal study tests resveratrol plus rice oil for fibromyalgia symptoms | Study evaluates links between migraines, mood disorders and IBS
April 20, 2016
News for the pain professional
SIGN UP ⋅   FORWARD
Pain Research News
Study: Skull skin may shunt current during brain stimulation
A cadaver study found that in electrical stimulation of the brain, which some research suggests can reduce pain, up to 90% of the current may be redirected by skin covering the skull. Researcher Gyorgy Buzsaki of New York University told the Cognitive Neuroscience Society's annual meeting it would take at least 4 milliamps of current to stimulate neurons in the brain, an amount roughly equal to a stun-gun discharge.
ScienceMag.org (4/20) 
LinkedIn Twitter Facebook Google+ Email
Animal study tests resveratrol plus rice oil for fibromyalgia symptoms
A study of mice found co-administering resveratrol and rice oil may reduce pain sensitivity and depression associated with fibromyalgia. The study in Pain Research and Treatment suggested reactive oxygen species may be associated with fibromyalgia symptoms.
Fibromyalgia News Today (4/18) 
LinkedIn Twitter Facebook Google+ Email
Other News
 
CMS Open Payments: What You Need to Know
As part of CMS Open Payments, pharmaceutical and industry manufacturers submitted data about their financial relationships with you - physicians and teaching hospitals. CMS encourages you to review that data before it is made available on a publicly accessible website. Learn more now!
Advertisement
Treatment News
Updated guideline says Botox safe, effective for chronic migraine
An updated guideline from the American Academy of Neurology lists Botox as a safe and effective treatment for chronic migraine and several other neurological conditions. The guidelines were published in the journal Neurology.
HealthDay News (4/18) 
LinkedIn Twitter Facebook Google+ Email
Research shows when spinal fusion may be better option
Treating spinal stenosis with decompression instead of spinal fusion may result in fewer complications while delivering similar pain relief, according to a study in the New England Journal of Medicine. Researchers said spinal fusion may be a better option for patients who have lumbar spondylolisthesis.
HealthDay News (4/13) 
LinkedIn Twitter Facebook Google+ Email
Policy & Trends
Groups ask Joint Commission to review pain management standards
Dozens of nonprofit groups, state officials and medical experts have asked the Joint Commission to reconsider standards for pain management, which they contend can lead to inappropriate prescribing of opioid drugs. The effort was led by Physicians for Responsible Opioid Prescribing, which also filed a petition with the CMS calling for some pain-related questions to be removed from patient-satisfaction surveys.
The Charlotte Observer (N.C.)/The Associated Press (4/13),  PhysiciansBriefing.com (4/13) 
LinkedIn Twitter Facebook Google+ Email
Survey: 98% of doctors prescribe opioids
Nearly all physicians will prescribe opioids for pain management despite evidence that alternative treatments can be more effective, according to a recent National Safety Council survey. More than two-thirds of respondents said they prescribe opioids because their patients expect them, and close to 90% said they struggle to refer patients for treatment of opioid abuse. "These findings are further proof that we need more education and training if we want to treat pain most effectively," said NSC medical adviser Dr. Don Teater.
RiskAndInsurance.com (4/18) 
LinkedIn Twitter Facebook Google+ Email
Other News
APS News
APS and Pfizer IGLC funding opportunity
APS and Pfizer Independent Grants for Learning and Change are excited to announce their collaboration in a new $2 million funding opportunity focused on improving care for individuals with chronic pain. It is the intent of this RFP to solicit applications related to the objectives in the National Pain Strategy, released last month by the assistant secretary of HHS. Now open -- this exciting opportunity will bring to light the topic of chronic pain and address the problems and objectives as articulated in the NPS. This RFP is being issued by APS with grant funding provided by Pfizer IGLC. Learn more.
LinkedIn Twitter Facebook Google+ Email
Meet APS in Austin!
The APS Annual Scientific Meeting is headed to Austin, Texas, May 11-14 for the 35th Annual Scientific Meeting! This is an exciting opportunity to network with your peers and attend the highly regarded education session! Don't miss the keynote address with Keith Wailoo, Ph.D., Townsend Martin Professor of History and Public Affairs, Princeton University, on "Pain: A Political History." When is pain real? Does too-liberal, overly compassionate relief create addiction? Is chronic pain a legitimate basis for disability claims and long-term benefits? What to do when end-of-life pain care resembles physician-assisted suicide or euthanasia? This lecture explores the political and cultural history of these complex medical and social debates. It will examine how pain medicine emerged as a legitimate yet controversial area of medical care; how physicians, patients, politicians and, ultimately, the courts have shaped ideas about pain and relief practices; and how the questions about who is in pain and how much relief they deserve became a powerful microcosm of broader debates over disability, citizenship, liberalism and conservatism in American society. Register now!
LinkedIn Twitter Facebook Google+ Email
  
  
The speed of your success is limited only by your dedication and what you're willing to sacrifice.
Nathan Morris,
financial coach and writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information